Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
193.2 USD | -0.48% | -1.01% | -25.35% |
12:00pm | Alzheimer's drug adoption in US slowed by doctors' skepticism | RE |
Apr. 19 | Needham Adjusts Price Target on Biogen to $294 From $300 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.35% | 28.22B | |
-2.68% | 85.68B | |
+4.08% | 41.4B | |
+54.31% | 24.64B | |
-4.52% | 16.98B | |
-42.09% | 13.29B | |
-17.77% | 11.66B | |
-12.10% | 11.65B | |
+0.75% | 8.18B | |
+3.32% | 7.78B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Mizuho Securities Cuts Biogen's Price Target to $270 From $300, Citing Aduhelm Sales Estimates; Neutral Rating Kept